Index by author

01 May 1999; volume 13, issue 5

A

  1. Aalbers, R

    1. Politiek, MJ, M Boorsma, and R Aalbers. "Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction." European Respiratory Journal 13.5 (1999): 988-992. Web. 27 Jan. 2021.

  2. Adelroth, E

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  3. Ahlf, K

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  4. Akkermans, RP

    1. Bijl-Hofland, ID et al "Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients." European Respiratory Journal 13.5 (1999): 955-960. Web. 27 Jan. 2021.

  5. Anderson, R

    1. Feldman, C et al "The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro." European Respiratory Journal 13.5 (1999): 1022-1028. Web. 27 Jan. 2021.

  6. Arends, JW

    1. Somers, VA et al "Additional value of K-ras point mutations in bronchial wash fluids for diagnosis of peripheral lung tumours." European Respiratory Journal 13.5 (1999): 1120-1124. Web. 27 Jan. 2021.

  7. Armengaud, A

    1. Vervloet, D et al "The prevalence of reported asthma is independent of exposure in house dust mite-sensitized children." European Respiratory Journal 13.5 (1999): 983-987. Web. 27 Jan. 2021.

  8. Arsalane, K

    1. Hermans, C et al "Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability." European Respiratory Journal 13.5 (1999): 1014-1021. Web. 27 Jan. 2021.

  9. Attal, P

    1. Coirault, C et al "Cross-bridge kinetics in fatigued mouse diaphragm." European Respiratory Journal 13.5 (1999): 1055-1061. Web. 27 Jan. 2021.

  10. Attefors, R

    1. Rylander, R, J Thorn, and R Attefors. "Airways inflammation among workers in a paper industry." European Respiratory Journal 13.5 (1999): 1151-1157. Web. 27 Jan. 2021.

  11. Ayres, J

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

B

  1. Barnes, N

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  2. Barnes, P

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  3. Barry, PW

    1. Barry, PW, and C O'Callaghan. "An in vitro analysis of the output of salbutamol from different nebulizers." European Respiratory Journal 13.5 (1999): 1164-1169. Web. 27 Jan. 2021.

  4. Bartholomew, HC

    1. James, AL et al "Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study." European Respiratory Journal 13.5 (1999): 1115-1119. Web. 27 Jan. 2021.

  5. Begin, P

    1. Begin, P, and A Grassino. "CO2-response in chronic obstructive pulmonary disease." European Respiratory Journal 13.5 (1999): 1212-1214. Web. 27 Jan. 2021.

  6. Bel, E

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  7. Bellemare, F

    1. Prandi, E, J Couture, and F Bellemare. "In normal subjects bracing impairs the function of the inspiratory muscles." European Respiratory Journal 13.5 (1999): 1078-1085. Web. 27 Jan. 2021.

  8. Berger, F

    1. Etienne, B et al "Aggressive primary mediastinal non-Hodgkin's lymphomas: a study of 29 cases." European Respiratory Journal 13.5 (1999): 1133-1138. Web. 27 Jan. 2021.

  9. Bernard, A

    1. Hermans, C et al "Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability." European Respiratory Journal 13.5 (1999): 1014-1021. Web. 27 Jan. 2021.
    2. Vandenplas, O et al "Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects." European Respiratory Journal 13.5 (1999): 1144-1150. Web. 27 Jan. 2021.

  10. Bijl-Hofland, ID

    1. Bijl-Hofland, ID et al "Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients." European Respiratory Journal 13.5 (1999): 955-960. Web. 27 Jan. 2021.

  11. Blanc, FX

    1. Coirault, C et al "Cross-bridge kinetics in fatigued mouse diaphragm." European Respiratory Journal 13.5 (1999): 1055-1061. Web. 27 Jan. 2021.

  12. Blanch, L

    1. Blanch, L et al "Volumetric capnography in patients with acute lung injury: effects of positive end-expiratory pressure." European Respiratory Journal 13.5 (1999): 1048-1054. Web. 27 Jan. 2021.

  13. Bombin, C

    1. Sastre, J et al "Occupational asthma induced by cephalosporins." European Respiratory Journal 13.5 (1999): 1189-1191. Web. 27 Jan. 2021.

  14. Boorsma, M

    1. Politiek, MJ, M Boorsma, and R Aalbers. "Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction." European Respiratory Journal 13.5 (1999): 988-992. Web. 27 Jan. 2021.

  15. Boulanger, J

    1. Vandenplas, O et al "Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects." European Respiratory Journal 13.5 (1999): 1144-1150. Web. 27 Jan. 2021.

  16. Boulet, LP

    1. Malo, JL et al "Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone." European Respiratory Journal 13.5 (1999): 993-998. Web. 27 Jan. 2021.

  17. Bramley, AM

    1. Dakhama, A et al "Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea-pigs." European Respiratory Journal 13.5 (1999): 976-982. Web. 27 Jan. 2021.

  18. Brown, J

    1. Malo, JL et al "Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone." European Respiratory Journal 13.5 (1999): 993-998. Web. 27 Jan. 2021.

  19. Burney, P

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

C

  1. Cartier, A

    1. Malo, JL et al "Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone." European Respiratory Journal 13.5 (1999): 993-998. Web. 27 Jan. 2021.

  2. Chabot, F

    1. Rosner, V et al "Validity of transcutaneous oxygen/carbon dioxide pressure measurement in the monitoring of mechanical ventilation in stable chronic respiratory failure." European Respiratory Journal 13.5 (1999): 1044-1047. Web. 27 Jan. 2021.

  3. Chan, NG

    1. Dakhama, A et al "Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea-pigs." European Respiratory Journal 13.5 (1999): 976-982. Web. 27 Jan. 2021.

  4. Chanez, P

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  5. Chaouat, A

    1. Chaouat, A et al "Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP." European Respiratory Journal 13.5 (1999): 1091-1096. Web. 27 Jan. 2021.
    2. Weitzenblum, E, A Chaouat, and R Kessler. "Long-term oxygen therapy: do current guidelines need revision?." European Respiratory Journal 13.5 (1999): 1209-1210. Web. 27 Jan. 2021.

  6. Charpin, D

    1. Vervloet, D et al "The prevalence of reported asthma is independent of exposure in house dust mite-sensitized children." European Respiratory Journal 13.5 (1999): 983-987. Web. 27 Jan. 2021.

  7. Chemla, D

    1. Coirault, C et al "Cross-bridge kinetics in fatigued mouse diaphragm." European Respiratory Journal 13.5 (1999): 1055-1061. Web. 27 Jan. 2021.
    2. Lecarpentier, Y et al "Diaphragm strength and cross-bridge properties during chronic growth hormone hypersecretion." European Respiratory Journal 13.5 (1999): 1070-1077. Web. 27 Jan. 2021.

  8. Chung, KF

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  9. Cloosterman, SG

    1. Bijl-Hofland, ID et al "Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients." European Respiratory Journal 13.5 (1999): 955-960. Web. 27 Jan. 2021.

  10. Coiffier, B

    1. Etienne, B et al "Aggressive primary mediastinal non-Hodgkin's lymphomas: a study of 29 cases." European Respiratory Journal 13.5 (1999): 1133-1138. Web. 27 Jan. 2021.

  11. Coirault, C

    1. Coirault, C et al "Cross-bridge kinetics in fatigued mouse diaphragm." European Respiratory Journal 13.5 (1999): 1055-1061. Web. 27 Jan. 2021.
    2. Lecarpentier, Y et al "Diaphragm strength and cross-bridge properties during chronic growth hormone hypersecretion." European Respiratory Journal 13.5 (1999): 1070-1077. Web. 27 Jan. 2021.

  12. Cole, PJ

    1. Feldman, C et al "The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro." European Respiratory Journal 13.5 (1999): 1022-1028. Web. 27 Jan. 2021.

  13. Connett, G

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  14. Cook, A

    1. Cullinan, P et al "Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees." European Respiratory Journal 13.5 (1999): 1139-1143. Web. 27 Jan. 2021.

  15. Cordier, JF

    1. Etienne, B et al "Aggressive primary mediastinal non-Hodgkin's lymphomas: a study of 29 cases." European Respiratory Journal 13.5 (1999): 1133-1138. Web. 27 Jan. 2021.

  16. Corrigan, C

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  17. Couture, J

    1. Prandi, E, J Couture, and F Bellemare. "In normal subjects bracing impairs the function of the inspiratory muscles." European Respiratory Journal 13.5 (1999): 1078-1085. Web. 27 Jan. 2021.

  18. Cullinan, P

    1. Cullinan, P et al "Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees." European Respiratory Journal 13.5 (1999): 1139-1143. Web. 27 Jan. 2021.

D

  1. Dakhama, A

    1. Dakhama, A et al "Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea-pigs." European Respiratory Journal 13.5 (1999): 976-982. Web. 27 Jan. 2021.

  2. de Andrade, AD

    1. Vervloet, D et al "The prevalence of reported asthma is independent of exposure in house dust mite-sensitized children." European Respiratory Journal 13.5 (1999): 983-987. Web. 27 Jan. 2021.

  3. de Blic, J

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  4. Decramer, M

    1. Houtmeyers, E et al "Regulation of mucociliary clearance in health and disease." European Respiratory Journal 13.5 (1999): 1177-1188. Web. 27 Jan. 2021.

  5. Dekhuijzen, PN

    1. van Balkom, RH et al "Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters." European Respiratory Journal 13.5 (1999): 1062-1069. Web. 27 Jan. 2021.

  6. de la Hoz, RE

    1. de la Hoz, RE. "Reactive airways dysfunction syndrome following exposure to a fluorocarbon." European Respiratory Journal 13.5 (1999): 1192-1194. Web. 27 Jan. 2021.

  7. Delaunois, L

    1. Vandenplas, O et al "Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects." European Respiratory Journal 13.5 (1999): 1144-1150. Web. 27 Jan. 2021.

  8. Delwiche, JP

    1. Vandenplas, O et al "Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects." European Respiratory Journal 13.5 (1999): 1144-1150. Web. 27 Jan. 2021.

  9. Divitini, ML

    1. James, AL et al "Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study." European Respiratory Journal 13.5 (1999): 1115-1119. Web. 27 Jan. 2021.

  10. Donnelly, SC

    1. Sallenave, JM et al "Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome." European Respiratory Journal 13.5 (1999): 1029-1036. Web. 27 Jan. 2021.

  11. Du, T

    1. Du, T et al "IL-3 does not affect the allergic airway responses and leukotriene production after allergen challenge in rats." European Respiratory Journal 13.5 (1999): 970-975. Web. 27 Jan. 2021.

  12. Dumarey, C

    1. Haile, S et al "Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma." European Respiratory Journal 13.5 (1999): 961-969. Web. 27 Jan. 2021.

  13. Dutau, H

    1. Vervloet, D et al "The prevalence of reported asthma is independent of exposure in house dust mite-sensitized children." European Respiratory Journal 13.5 (1999): 983-987. Web. 27 Jan. 2021.

  14. Duurkens, VA

    1. Maesen, BL et al "Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease." European Respiratory Journal 13.5 (1999): 1103-1108. Web. 27 Jan. 2021.

  15. Duvernelle, C

    1. Kassel, O et al "Human bronchial smooth muscle cells in culture produce stem cell factor." European Respiratory Journal 13.5 (1999): 951-954. Web. 27 Jan. 2021.

E

  1. Elliott, MW

    1. Watson, JP, J Nolan, and MW Elliott. "Autonomic dysfunction in patients with nocturnal hypoventilation in extrapulmonary restrictive disease." European Respiratory Journal 13.5 (1999): 1097-1102. Web. 27 Jan. 2021.

  2. Etienne, B

    1. Etienne, B et al "Aggressive primary mediastinal non-Hodgkin's lymphomas: a study of 29 cases." European Respiratory Journal 13.5 (1999): 1133-1138. Web. 27 Jan. 2021.

  3. Eum, SY

    1. Haile, S et al "Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma." European Respiratory Journal 13.5 (1999): 961-969. Web. 27 Jan. 2021.

F

  1. Fabbri, L

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  2. Fabel, H

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  3. Falmagne, P

    1. Hermans, C et al "Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability." European Respiratory Journal 13.5 (1999): 1014-1021. Web. 27 Jan. 2021.

  4. Feldman, C

    1. Feldman, C et al "The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro." European Respiratory Journal 13.5 (1999): 1022-1028. Web. 27 Jan. 2021.

  5. Fernandez, R

    1. Blanch, L et al "Volumetric capnography in patients with acute lung injury: effects of positive end-expiratory pressure." European Respiratory Journal 13.5 (1999): 1048-1054. Web. 27 Jan. 2021.

  6. Folgering, H

    1. Folgering, H. "CO2-response in chronic obstructive pulmonary disease." European Respiratory Journal 13.5 (1999): 1211-1214. Web. 27 Jan. 2021.

  7. Folgering, HT

    1. van Balkom, RH et al "Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters." European Respiratory Journal 13.5 (1999): 1062-1069. Web. 27 Jan. 2021.
    2. Bijl-Hofland, ID et al "Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients." European Respiratory Journal 13.5 (1999): 955-960. Web. 27 Jan. 2021.

  8. Fransen, JA

    1. van Balkom, RH et al "Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters." European Respiratory Journal 13.5 (1999): 1062-1069. Web. 27 Jan. 2021.

  9. Fraund, S

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  10. Frossard, N

    1. Kassel, O et al "Human bronchial smooth muscle cells in culture produce stem cell factor." European Respiratory Journal 13.5 (1999): 951-954. Web. 27 Jan. 2021.

  11. Furukawa, M

    1. Suzuki, H et al "IL-12 receptor beta2 and CD30 expression in paranasal sinus mucosa of patients with chronic sinusitis." European Respiratory Journal 13.5 (1999): 1008-1013. Web. 27 Jan. 2021.

G

  1. Garlepp, MJ

    1. Watkins, DN et al "Expression and localization of COX-2 in human airways and cultured airway epithelial cells." European Respiratory Journal 13.5 (1999): 999-1007. Web. 27 Jan. 2021.

  2. Gasser, B

    1. Kassel, O et al "Human bronchial smooth muscle cells in culture produce stem cell factor." European Respiratory Journal 13.5 (1999): 951-954. Web. 27 Jan. 2021.

  3. Gauldie, J

    1. Sallenave, JM et al "Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome." European Respiratory Journal 13.5 (1999): 1029-1036. Web. 27 Jan. 2021.

  4. Gayan-Ramirez, G

    1. Houtmeyers, E et al "Regulation of mucociliary clearance in health and disease." European Respiratory Journal 13.5 (1999): 1177-1188. Web. 27 Jan. 2021.

  5. Ghezzo, H

    1. Malo, JL et al "Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone." European Respiratory Journal 13.5 (1999): 993-998. Web. 27 Jan. 2021.

  6. Godard, P

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  7. Goldstone, JC

    1. Stell, IM et al "An in vivo comparison of a catheter mounted pressure transducer system with conventional balloon catheters." European Respiratory Journal 13.5 (1999): 1158-1163. Web. 27 Jan. 2021.

  8. Gordon, S

    1. Cullinan, P et al "Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees." European Respiratory Journal 13.5 (1999): 1139-1143. Web. 27 Jan. 2021.

  9. Gosselink, R

    1. Houtmeyers, E et al "Regulation of mucociliary clearance in health and disease." European Respiratory Journal 13.5 (1999): 1177-1188. Web. 27 Jan. 2021.

  10. Goto, S

    1. Suzuki, H et al "IL-12 receptor beta2 and CD30 expression in paranasal sinus mucosa of patients with chronic sinusitis." European Respiratory Journal 13.5 (1999): 1008-1013. Web. 27 Jan. 2021.

  11. Grant, IS

    1. Sallenave, JM et al "Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome." European Respiratory Journal 13.5 (1999): 1029-1036. Web. 27 Jan. 2021.

  12. Grassino, A

    1. Begin, P, and A Grassino. "CO2-response in chronic obstructive pulmonary disease." European Respiratory Journal 13.5 (1999): 1212-1214. Web. 27 Jan. 2021.

  13. Guillaud, PH

    1. Etienne, B et al "Aggressive primary mediastinal non-Hodgkin's lymphomas: a study of 29 cases." European Respiratory Journal 13.5 (1999): 1133-1138. Web. 27 Jan. 2021.

H

  1. Haile, S

    1. Haile, S et al "Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma." European Respiratory Journal 13.5 (1999): 961-969. Web. 27 Jan. 2021.

  2. Hammad, H

    1. Chaouat, A et al "Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP." European Respiratory Journal 13.5 (1999): 1091-1096. Web. 27 Jan. 2021.

  3. Hannhart, B

    1. Rosner, V et al "Validity of transcutaneous oxygen/carbon dioxide pressure measurement in the monitoring of mechanical ventilation in stable chronic respiratory failure." European Respiratory Journal 13.5 (1999): 1044-1047. Web. 27 Jan. 2021.

  4. Harringer, W

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  5. Haslett, C

    1. Sallenave, JM et al "Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome." European Respiratory Journal 13.5 (1999): 1029-1036. Web. 27 Jan. 2021.

  6. Haverich, A

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  7. Hegele, RG

    1. Dakhama, A et al "Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea-pigs." European Respiratory Journal 13.5 (1999): 976-982. Web. 27 Jan. 2021.

  8. Hermans, C

    1. Hermans, C et al "Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability." European Respiratory Journal 13.5 (1999): 1014-1021. Web. 27 Jan. 2021.

  9. Heusser, C

    1. Haile, S et al "Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma." European Respiratory Journal 13.5 (1999): 961-969. Web. 27 Jan. 2021.

  10. Hill, SL

    1. Hill, SL, and B Webber. "Mucus transport and physiotherapy--a new series." European Respiratory Journal 13.5 (1999): 949-950. Web. 27 Jan. 2021.

  11. Hoeper, MM

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  12. Hohlfeld, JM

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  13. Holgate, ST

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  14. Houtmeyers, E

    1. Houtmeyers, E et al "Regulation of mucociliary clearance in health and disease." European Respiratory Journal 13.5 (1999): 1177-1188. Web. 27 Jan. 2021.

  15. Huerre, M

    1. Haile, S et al "Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma." European Respiratory Journal 13.5 (1999): 961-969. Web. 27 Jan. 2021.

I

  1. Ikeda, K

    1. Suzuki, H et al "IL-12 receptor beta2 and CD30 expression in paranasal sinus mucosa of patients with chronic sinusitis." European Respiratory Journal 13.5 (1999): 1008-1013. Web. 27 Jan. 2021.

  2. Ind, P

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  3. Ishii, T

    1. Teramoto, S et al "Recombinant E1-deleted adenovirus vector induces apoptosis in two lung cancer cell lines." European Respiratory Journal 13.5 (1999): 1125-1132. Web. 27 Jan. 2021.

J

  1. Jamart, J

    1. Vandenplas, O et al "Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects." European Respiratory Journal 13.5 (1999): 1144-1150. Web. 27 Jan. 2021.

  2. James, AL

    1. James, AL et al "Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study." European Respiratory Journal 13.5 (1999): 1115-1119. Web. 27 Jan. 2021.

  3. Joos, G

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

K

  1. Kassel, O

    1. Kassel, O et al "Human bronchial smooth muscle cells in culture produce stem cell factor." European Respiratory Journal 13.5 (1999): 951-954. Web. 27 Jan. 2021.

  2. Kelkel, E

    1. Orliaguet, O et al "Hunter's syndrome and associated sleep apnoea cured by CPAP and surgery." European Respiratory Journal 13.5 (1999): 1195-1197. Web. 27 Jan. 2021.

  3. Kerstjens, H

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  4. Kessler, R

    1. Chaouat, A et al "Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP." European Respiratory Journal 13.5 (1999): 1091-1096. Web. 27 Jan. 2021.
    2. Weitzenblum, E, A Chaouat, and R Kessler. "Long-term oxygen therapy: do current guidelines need revision?." European Respiratory Journal 13.5 (1999): 1209-1210. Web. 27 Jan. 2021.

  5. Kiely, JL

    1. Kiely, JL, M Murphy, and WT McNicholas. "Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study." European Respiratory Journal 13.5 (1999): 1086-1090. Web. 27 Jan. 2021.

  6. Killian, KJ

    1. Killian, KJ. "Measurements of dyspnoea during bronchoconstriction." European Respiratory Journal 13.5 (1999): 943-946. Web. 27 Jan. 2021.

  7. Knight, DA

    1. Watkins, DN et al "Expression and localization of COX-2 in human airways and cultured airway epithelial cells." European Respiratory Journal 13.5 (1999): 999-1007. Web. 27 Jan. 2021.

  8. Knoops, B

    1. Hermans, C et al "Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability." European Respiratory Journal 13.5 (1999): 1014-1021. Web. 27 Jan. 2021.

  9. Knuiman, MW

    1. James, AL et al "Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study." European Respiratory Journal 13.5 (1999): 1115-1119. Web. 27 Jan. 2021.

  10. Krieger, J

    1. Chaouat, A et al "Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP." European Respiratory Journal 13.5 (1999): 1091-1096. Web. 27 Jan. 2021.

  11. Krug, N

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

L

  1. Lange, P

    1. Prescott, E, P Lange, and J Vestbo. "Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study." European Respiratory Journal 13.5 (1999): 1109-1114. Web. 27 Jan. 2021.

  2. Lanteaume, A

    1. Vervloet, D et al "The prevalence of reported asthma is independent of exposure in house dust mite-sensitized children." European Respiratory Journal 13.5 (1999): 983-987. Web. 27 Jan. 2021.

  3. Laviolette, M

    1. Malo, JL et al "Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone." European Respiratory Journal 13.5 (1999): 993-998. Web. 27 Jan. 2021.

  4. Lecarpentier, Y

    1. Coirault, C et al "Cross-bridge kinetics in fatigued mouse diaphragm." European Respiratory Journal 13.5 (1999): 1055-1061. Web. 27 Jan. 2021.
    2. Lecarpentier, Y et al "Diaphragm strength and cross-bridge properties during chronic growth hormone hypersecretion." European Respiratory Journal 13.5 (1999): 1070-1077. Web. 27 Jan. 2021.

  5. Lefort, J

    1. Haile, S et al "Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma." European Respiratory Journal 13.5 (1999): 961-969. Web. 27 Jan. 2021.

  6. Lenzo, JC

    1. Watkins, DN et al "Expression and localization of COX-2 in human airways and cultured airway epithelial cells." European Respiratory Journal 13.5 (1999): 999-1007. Web. 27 Jan. 2021.

  7. Leuenberger, P

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  8. Levy, P

    1. Orliaguet, O et al "Hunter's syndrome and associated sleep apnoea cured by CPAP and surgery." European Respiratory Journal 13.5 (1999): 1195-1197. Web. 27 Jan. 2021.

  9. Lluch-Bernal, M

    1. Sastre, J et al "Occupational asthma induced by cephalosporins." European Respiratory Journal 13.5 (1999): 1189-1191. Web. 27 Jan. 2021.

  10. Lofdahl, CG

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  11. Loire, R

    1. Etienne, B et al "Aggressive primary mediastinal non-Hodgkin's lymphomas: a study of 29 cases." European Respiratory Journal 13.5 (1999): 1133-1138. Web. 27 Jan. 2021.

  12. Lopez-Aguilar, J

    1. Blanch, L et al "Volumetric capnography in patients with acute lung injury: effects of positive end-expiratory pressure." European Respiratory Journal 13.5 (1999): 1048-1054. Web. 27 Jan. 2021.

  13. Lovell, AT

    1. Stell, IM et al "An in vivo comparison of a catheter mounted pressure transducer system with conventional balloon catheters." European Respiratory Journal 13.5 (1999): 1158-1163. Web. 27 Jan. 2021.

  14. Lucangelo, U

    1. Blanch, L et al "Volumetric capnography in patients with acute lung injury: effects of positive end-expiratory pressure." European Respiratory Journal 13.5 (1999): 1048-1054. Web. 27 Jan. 2021.

M

  1. Maesen, BL

    1. Maesen, BL et al "Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease." European Respiratory Journal 13.5 (1999): 1103-1108. Web. 27 Jan. 2021.

  2. Magnussen, H

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  3. Malo, JL

    1. Malo, JL et al "Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone." European Respiratory Journal 13.5 (1999): 993-998. Web. 27 Jan. 2021.

  4. Mark, S

    1. Malo, JL et al "Skin bruising, adrenal function and markers of bone metabolism in asthmatics using inhaled beclomethasone and fluticasone." European Respiratory Journal 13.5 (1999): 993-998. Web. 27 Jan. 2021.

  5. Martin, JG

    1. Du, T et al "IL-3 does not affect the allergic airway responses and leukotriene production after allergen challenge in rats." European Respiratory Journal 13.5 (1999): 970-975. Web. 27 Jan. 2021.

  6. Massard, G

    1. Kassel, O et al "Human bronchial smooth muscle cells in culture produce stem cell factor." European Respiratory Journal 13.5 (1999): 951-954. Web. 27 Jan. 2021.

  7. Matsui, H

    1. Teramoto, S et al "Recombinant E1-deleted adenovirus vector induces apoptosis in two lung cancer cell lines." European Respiratory Journal 13.5 (1999): 1125-1132. Web. 27 Jan. 2021.

  8. Matsuse, T

    1. Teramoto, S et al "Recombinant E1-deleted adenovirus vector induces apoptosis in two lung cancer cell lines." European Respiratory Journal 13.5 (1999): 1125-1132. Web. 27 Jan. 2021.

  9. McDonald, JC

    1. Cullinan, P et al "Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees." European Respiratory Journal 13.5 (1999): 1139-1143. Web. 27 Jan. 2021.

  10. McKay, KO

    1. Dakhama, A et al "Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea-pigs." European Respiratory Journal 13.5 (1999): 976-982. Web. 27 Jan. 2021.

  11. McKenzie, S

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  12. McNicholas, WT

    1. Kiely, JL, M Murphy, and WT McNicholas. "Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study." European Respiratory Journal 13.5 (1999): 1086-1090. Web. 27 Jan. 2021.

  13. Mercadier, JJ

    1. Lecarpentier, Y et al "Diaphragm strength and cross-bridge properties during chronic growth hormone hypersecretion." European Respiratory Journal 13.5 (1999): 1070-1077. Web. 27 Jan. 2021.

  14. Mokgobu, I

    1. Feldman, C et al "The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro." European Respiratory Journal 13.5 (1999): 1022-1028. Web. 27 Jan. 2021.

  15. Moxham, J

    1. Stell, IM et al "An in vivo comparison of a catheter mounted pressure transducer system with conventional balloon catheters." European Respiratory Journal 13.5 (1999): 1158-1163. Web. 27 Jan. 2021.

  16. Murphy, M

    1. Kiely, JL, M Murphy, and WT McNicholas. "Subjective efficacy of nasal CPAP therapy in obstructive sleep apnoea syndrome: a prospective controlled study." European Respiratory Journal 13.5 (1999): 1086-1090. Web. 27 Jan. 2021.

  17. Musk, AW

    1. James, AL et al "Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study." European Respiratory Journal 13.5 (1999): 1115-1119. Web. 27 Jan. 2021.

N

  1. Nieuwenhuijsen, MJ

    1. Cullinan, P et al "Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees." European Respiratory Journal 13.5 (1999): 1139-1143. Web. 27 Jan. 2021.

  2. Nolan, J

    1. Watson, JP, J Nolan, and MW Elliott. "Autonomic dysfunction in patients with nocturnal hypoventilation in extrapulmonary restrictive disease." European Respiratory Journal 13.5 (1999): 1097-1102. Web. 27 Jan. 2021.

  3. Novalbos, A

    1. Sastre, J et al "Occupational asthma induced by cephalosporins." European Respiratory Journal 13.5 (1999): 1189-1191. Web. 27 Jan. 2021.

O

  1. O'Callaghan, C

    1. Barry, PW, and C O'Callaghan. "An in vitro analysis of the output of salbutamol from different nebulizers." European Respiratory Journal 13.5 (1999): 1164-1169. Web. 27 Jan. 2021.

  2. Ohga, E

    1. Teramoto, S et al "Recombinant E1-deleted adenovirus vector induces apoptosis in two lung cancer cell lines." European Respiratory Journal 13.5 (1999): 1125-1132. Web. 27 Jan. 2021.

  3. Orliaguet, O

    1. Orliaguet, O et al "Hunter's syndrome and associated sleep apnoea cured by CPAP and surgery." European Respiratory Journal 13.5 (1999): 1195-1197. Web. 27 Jan. 2021.

  4. Oshima, T

    1. Suzuki, H et al "IL-12 receptor beta2 and CD30 expression in paranasal sinus mucosa of patients with chronic sinusitis." European Respiratory Journal 13.5 (1999): 1008-1013. Web. 27 Jan. 2021.

  5. Oswald, M

    1. Chaouat, A et al "Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP." European Respiratory Journal 13.5 (1999): 1091-1096. Web. 27 Jan. 2021.

  6. Ouchi, Y

    1. Teramoto, S et al "Recombinant E1-deleted adenovirus vector induces apoptosis in two lung cancer cell lines." European Respiratory Journal 13.5 (1999): 1125-1132. Web. 27 Jan. 2021.

P

  1. Pascal, L

    1. Vervloet, D et al "The prevalence of reported asthma is independent of exposure in house dust mite-sensitized children." European Respiratory Journal 13.5 (1999): 983-987. Web. 27 Jan. 2021.

  2. Pepin, JL

    1. Orliaguet, O et al "Hunter's syndrome and associated sleep apnoea cured by CPAP and surgery." European Respiratory Journal 13.5 (1999): 1195-1197. Web. 27 Jan. 2021.

  3. Peroni, DJ

    1. Watkins, DN et al "Expression and localization of COX-2 in human airways and cultured airway epithelial cells." European Respiratory Journal 13.5 (1999): 999-1007. Web. 27 Jan. 2021.

  4. Pinel, N

    1. Orliaguet, O et al "Hunter's syndrome and associated sleep apnoea cured by CPAP and surgery." European Respiratory Journal 13.5 (1999): 1195-1197. Web. 27 Jan. 2021.

  5. Politiek, MJ

    1. Politiek, MJ, M Boorsma, and R Aalbers. "Comparison of formoterol, salbutamol and salmeterol in methacholine-induced severe bronchoconstriction." European Respiratory Journal 13.5 (1999): 988-992. Web. 27 Jan. 2021.

  6. Polu, JM

    1. Rosner, V et al "Validity of transcutaneous oxygen/carbon dioxide pressure measurement in the monitoring of mechanical ventilation in stable chronic respiratory failure." European Respiratory Journal 13.5 (1999): 1044-1047. Web. 27 Jan. 2021.

  7. Postma, D

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  8. Powell, WS

    1. Du, T et al "IL-3 does not affect the allergic airway responses and leukotriene production after allergen challenge in rats." European Respiratory Journal 13.5 (1999): 970-975. Web. 27 Jan. 2021.

  9. Prandi, E

    1. Prandi, E, J Couture, and F Bellemare. "In normal subjects bracing impairs the function of the inspiratory muscles." European Respiratory Journal 13.5 (1999): 1078-1085. Web. 27 Jan. 2021.

  10. Prescott, E

    1. Prescott, E, P Lange, and J Vestbo. "Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study." European Respiratory Journal 13.5 (1999): 1109-1114. Web. 27 Jan. 2021.

Q

  1. Quirce, S

    1. Sastre, J et al "Occupational asthma induced by cephalosporins." European Respiratory Journal 13.5 (1999): 1189-1191. Web. 27 Jan. 2021.

R

  1. Renzi, PM

    1. Du, T et al "IL-3 does not affect the allergic airway responses and leukotriene production after allergen challenge in rats." European Respiratory Journal 13.5 (1999): 970-975. Web. 27 Jan. 2021.

  2. Riou, B

    1. Lecarpentier, Y et al "Diaphragm strength and cross-bridge properties during chronic growth hormone hypersecretion." European Respiratory Journal 13.5 (1999): 1070-1077. Web. 27 Jan. 2021.

  3. Robertson, C

    1. Sallenave, JM et al "Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome." European Respiratory Journal 13.5 (1999): 1029-1036. Web. 27 Jan. 2021.

  4. Romero, PV

    1. Blanch, L et al "Volumetric capnography in patients with acute lung injury: effects of positive end-expiratory pressure." European Respiratory Journal 13.5 (1999): 1048-1054. Web. 27 Jan. 2021.

  5. Rosner, V

    1. Rosner, V et al "Validity of transcutaneous oxygen/carbon dioxide pressure measurement in the monitoring of mechanical ventilation in stable chronic respiratory failure." European Respiratory Journal 13.5 (1999): 1044-1047. Web. 27 Jan. 2021.

  6. Ryan, G

    1. James, AL et al "Associations between white blood cell count, lung function, respiratory illness and mortality: the Busselton Health Study." European Respiratory Journal 13.5 (1999): 1115-1119. Web. 27 Jan. 2021.

  7. Rylander, R

    1. Rylander, R, J Thorn, and R Attefors. "Airways inflammation among workers in a paper industry." European Respiratory Journal 13.5 (1999): 1151-1157. Web. 27 Jan. 2021.

S

  1. Saetta, M

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  2. Sallenave, JM

    1. Sallenave, JM et al "Secretory leukocyte proteinase inhibitor is preferentially increased in patients with acute respiratory distress syndrome." European Respiratory Journal 13.5 (1999): 1029-1036. Web. 27 Jan. 2021.

  3. Salmeron, S

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  4. Sambuc, R

    1. Vervloet, D et al "The prevalence of reported asthma is independent of exposure in house dust mite-sensitized children." European Respiratory Journal 13.5 (1999): 983-987. Web. 27 Jan. 2021.

  5. Sastre, J

    1. Sastre, J et al "Occupational asthma induced by cephalosporins." European Respiratory Journal 13.5 (1999): 1189-1191. Web. 27 Jan. 2021.

  6. Schellenberg, RR

    1. Dakhama, A et al "Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea-pigs." European Respiratory Journal 13.5 (1999): 976-982. Web. 27 Jan. 2021.

  7. Schmidlin, F

    1. Kassel, O et al "Human bronchial smooth muscle cells in culture produce stem cell factor." European Respiratory Journal 13.5 (1999): 951-954. Web. 27 Jan. 2021.

  8. Sforza, E

    1. Chaouat, A et al "Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP." European Respiratory Journal 13.5 (1999): 1091-1096. Web. 27 Jan. 2021.

  9. Sibille, Y

    1. Vandenplas, O et al "Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects." European Respiratory Journal 13.5 (1999): 1144-1150. Web. 27 Jan. 2021.

  10. Somers, VA

    1. Somers, VA et al "Additional value of K-ras point mutations in bronchial wash fluids for diagnosis of peripheral lung tumours." European Respiratory Journal 13.5 (1999): 1120-1124. Web. 27 Jan. 2021.

  11. Stamatis, G

    1. Teschler, H, AB Thompson, and G Stamatis. "Short- and long-term functional results after lung volume reduction surgery for severe emphysema." European Respiratory Journal 13.5 (1999): 1170-1176. Web. 27 Jan. 2021.

  12. Staquet, P

    1. Vandenplas, O et al "Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects." European Respiratory Journal 13.5 (1999): 1144-1150. Web. 27 Jan. 2021.

  13. Stell, IM

    1. Stell, IM et al "An in vivo comparison of a catheter mounted pressure transducer system with conventional balloon catheters." European Respiratory Journal 13.5 (1999): 1158-1163. Web. 27 Jan. 2021.

  14. Sterk, P

    1. Chung, KF et al "Difficult/therapy-resistant asthma: the need for an integrated approach to define clinical phenotypes, evaluate risk factors, understand pathophysiology and find novel therapies. ERS Task Force on Difficult/Therapy-Resistant Asthma. European Respiratory Society." European Respiratory Journal 13.5 (1999): 1198-1208. Web. 27 Jan. 2021.

  15. Struber, M

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  16. Suter, PM

    1. Suter, PM. "Elastase and its physiological inhibitors in ARDS: what decides between inflammatory storm or dead calm?." European Respiratory Journal 13.5 (1999): 947-948. Web. 27 Jan. 2021.

  17. Suzuki, H

    1. Suzuki, H et al "IL-12 receptor beta2 and CD30 expression in paranasal sinus mucosa of patients with chronic sinusitis." European Respiratory Journal 13.5 (1999): 1008-1013. Web. 27 Jan. 2021.

T

  1. Takasaka, T

    1. Suzuki, H et al "IL-12 receptor beta2 and CD30 expression in paranasal sinus mucosa of patients with chronic sinusitis." European Respiratory Journal 13.5 (1999): 1008-1013. Web. 27 Jan. 2021.

  2. Taylor, AJ

    1. Cullinan, P et al "Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees." European Respiratory Journal 13.5 (1999): 1139-1143. Web. 27 Jan. 2021.

  3. Tee, RD

    1. Cullinan, P et al "Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees." European Respiratory Journal 13.5 (1999): 1139-1143. Web. 27 Jan. 2021.

  4. ten Velde, GP

    1. Somers, VA et al "Additional value of K-ras point mutations in bronchial wash fluids for diagnosis of peripheral lung tumours." European Respiratory Journal 13.5 (1999): 1120-1124. Web. 27 Jan. 2021.

  5. Teramoto, S

    1. Teramoto, S et al "Recombinant E1-deleted adenovirus vector induces apoptosis in two lung cancer cell lines." European Respiratory Journal 13.5 (1999): 1125-1132. Web. 27 Jan. 2021.

  6. Teschler, H

    1. Teschler, H, AB Thompson, and G Stamatis. "Short- and long-term functional results after lung volume reduction surgery for severe emphysema." European Respiratory Journal 13.5 (1999): 1170-1176. Web. 27 Jan. 2021.

  7. Theron, A

    1. Feldman, C et al "The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro." European Respiratory Journal 13.5 (1999): 1022-1028. Web. 27 Jan. 2021.

  8. Thompson, AB

    1. Teschler, H, AB Thompson, and G Stamatis. "Short- and long-term functional results after lung volume reduction surgery for severe emphysema." European Respiratory Journal 13.5 (1999): 1170-1176. Web. 27 Jan. 2021.

  9. Thompson, PJ

    1. Watkins, DN et al "Expression and localization of COX-2 in human airways and cultured airway epithelial cells." European Respiratory Journal 13.5 (1999): 999-1007. Web. 27 Jan. 2021.

  10. Thorn, J

    1. Rylander, R, J Thorn, and R Attefors. "Airways inflammation among workers in a paper industry." European Respiratory Journal 13.5 (1999): 1151-1157. Web. 27 Jan. 2021.

  11. Thunnissen, FB

    1. Somers, VA et al "Additional value of K-ras point mutations in bronchial wash fluids for diagnosis of peripheral lung tumours." European Respiratory Journal 13.5 (1999): 1120-1124. Web. 27 Jan. 2021.

  12. Tompkins, S

    1. Stell, IM et al "An in vivo comparison of a catheter mounted pressure transducer system with conventional balloon catheters." European Respiratory Journal 13.5 (1999): 1158-1163. Web. 27 Jan. 2021.

  13. Toubeau, G

    1. Hermans, C et al "Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability." European Respiratory Journal 13.5 (1999): 1014-1021. Web. 27 Jan. 2021.

U

  1. Umpierrez, A

    1. Sastre, J et al "Occupational asthma induced by cephalosporins." European Respiratory Journal 13.5 (1999): 1189-1191. Web. 27 Jan. 2021.

V

  1. van Balkom, RH

    1. van Balkom, RH et al "Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters." European Respiratory Journal 13.5 (1999): 1062-1069. Web. 27 Jan. 2021.

  2. van den Bosch, JM

    1. Maesen, BL et al "Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease." European Respiratory Journal 13.5 (1999): 1103-1108. Web. 27 Jan. 2021.

  3. van den Hoogen, H

    1. Bijl-Hofland, ID et al "Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients." European Respiratory Journal 13.5 (1999): 955-960. Web. 27 Jan. 2021.

  4. Vandenplas, O

    1. Vandenplas, O et al "Pulmonary effects of short-term exposure to low levels of toluene diisocyanate in asymptomatic subjects." European Respiratory Journal 13.5 (1999): 1144-1150. Web. 27 Jan. 2021.

  5. van der Heijden, HF

    1. van Balkom, RH et al "Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters." European Respiratory Journal 13.5 (1999): 1062-1069. Web. 27 Jan. 2021.

  6. van Henten, AM

    1. Somers, VA et al "Additional value of K-ras point mutations in bronchial wash fluids for diagnosis of peripheral lung tumours." European Respiratory Journal 13.5 (1999): 1120-1124. Web. 27 Jan. 2021.

  7. van Herwaarden, CL

    1. van Balkom, RH et al "Effects of anabolic steroids on diaphragm impairment induced by methylprednisolone in emphysematous hamsters." European Respiratory Journal 13.5 (1999): 1062-1069. Web. 27 Jan. 2021.

  8. van Schayck, CP

    1. Bijl-Hofland, ID et al "Measuring breathlessness during histamine challenge: a simple standardized procedure in asthmatic patients." European Respiratory Journal 13.5 (1999): 955-960. Web. 27 Jan. 2021.

  9. Vargaftig, BB

    1. Haile, S et al "Suppression of immediate and late responses to antigen by a non-anaphylactogenic anti-IgE antibody in a murine model of asthma." European Respiratory Journal 13.5 (1999): 961-969. Web. 27 Jan. 2021.

  10. Veale, D

    1. Orliaguet, O et al "Hunter's syndrome and associated sleep apnoea cured by CPAP and surgery." European Respiratory Journal 13.5 (1999): 1195-1197. Web. 27 Jan. 2021.

  11. Venables, KM

    1. Cullinan, P et al "Allergen exposure, atopy and smoking as determinants of allergy to rats in a cohort of laboratory employees." European Respiratory Journal 13.5 (1999): 1139-1143. Web. 27 Jan. 2021.

  12. Vervloet, D

    1. Vervloet, D et al "The prevalence of reported asthma is independent of exposure in house dust mite-sensitized children." European Respiratory Journal 13.5 (1999): 983-987. Web. 27 Jan. 2021.

  13. Vestbo, J

    1. Prescott, E, P Lange, and J Vestbo. "Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study." European Respiratory Journal 13.5 (1999): 1109-1114. Web. 27 Jan. 2021.

W

  1. Warnecke, G

    1. Hohlfeld, JM et al "Exogenous surfactant improves survival and surfactant function in ischaemia-reperfusion injury in minipigs." European Respiratory Journal 13.5 (1999): 1037-1043. Web. 27 Jan. 2021.

  2. Watkins, DN

    1. Watkins, DN et al "Expression and localization of COX-2 in human airways and cultured airway epithelial cells." European Respiratory Journal 13.5 (1999): 999-1007. Web. 27 Jan. 2021.

  3. Watson, JP

    1. Watson, JP, J Nolan, and MW Elliott. "Autonomic dysfunction in patients with nocturnal hypoventilation in extrapulmonary restrictive disease." European Respiratory Journal 13.5 (1999): 1097-1102. Web. 27 Jan. 2021.

  4. Webber, B

    1. Hill, SL, and B Webber. "Mucus transport and physiotherapy--a new series." European Respiratory Journal 13.5 (1999): 949-950. Web. 27 Jan. 2021.

  5. Weitzenblum, E

    1. Chaouat, A et al "Prognostic value of lung function and pulmonary haemodynamics in OSA patients treated with CPAP." European Respiratory Journal 13.5 (1999): 1091-1096. Web. 27 Jan. 2021.
    2. Weitzenblum, E, A Chaouat, and R Kessler. "Long-term oxygen therapy: do current guidelines need revision?." European Respiratory Journal 13.5 (1999): 1209-1210. Web. 27 Jan. 2021.

  6. Westermann, CJ

    1. Maesen, BL et al "Effects of formoterol in apparently poorly reversible chronic obstructive pulmonary disease." European Respiratory Journal 13.5 (1999): 1103-1108. Web. 27 Jan. 2021.

  7. Wiedig, M

    1. Hermans, C et al "Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability." European Respiratory Journal 13.5 (1999): 1014-1021. Web. 27 Jan. 2021.

  8. Wilson, R

    1. Feldman, C et al "The effects of ketolides on bioactive phospholipid-induced injury to human respiratory epithelium in vitro." European Respiratory Journal 13.5 (1999): 1022-1028. Web. 27 Jan. 2021.

X

  1. Xu, LJ

    1. Du, T et al "IL-3 does not affect the allergic airway responses and leukotriene production after allergen challenge in rats." European Respiratory Journal 13.5 (1999): 970-975. Web. 27 Jan. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts